Hospital outpatient pharmacy leaders cite staffing shortages, managing multiple vendors, and navigating insurer red tape—specialty drug referrals and prior authorization requirements, specifically—among top workplace challenges, a new survey finds. As 340B providers continue to grapple with pharmaceutical manufacturer contract pharmacy
…
Congress’ attitude toward the 340B program will likely change in 2023 and 2024 because of November’s midterm election results, 340B Report Publisher and CEO Ted Slafsky predicts in his latest column for Omnicell.
It is customary for the party that
…
SPONSORED CONTENT
For decades, the 340B drug pricing program has served an important purpose by helping hospitals and other covered entities receive discounted prices on drugs to offset care provided to vulnerable, underserved populations.
But over the past several years, drug companies have started pushing back on the 340B program
…
It’s not just the drug industry stepping up its effort to influence the public and policymakers over the increasingly heated battle over the 340B program.
Groups that represent 340B hospitals and hospital pharmacists have launched a digital advertising campaign “to
…
The clerk of the U.S. Supreme Court on Monday formally notified the clerk of a federal appeals court in Washington, D.C., and lawyers for three hospital groups and three health systems of the high court’s June 15 judgement in the
…
SPONSORED CONTENT
In Democracy in America, French sociologist and political theorist Alexis de Tocqueville spoke of the importance of advocacy to American civil society: “In the United States, as soon as several inhabitants have taken an opinion or an idea they wish to promote in society, they seek
…
U.S. Senate Democrats are hopeful that drug pricing legislation will be passed by early next month via a budget reconciliation process requiring just 50 Democratic votes, a Democratic source with knowledge of the process told 340B Report.
“Our expectation is, we’re
…
Pharmaceutical Research and Manufacturers of America ran a full-page advertisement in the A section of The Washington Post this morning blasting 340B hospitals and drug store chains. According to a PhRMA spokesperson, it is part of a new ad campaign
…
Groups that represent 340B hospitals praised the Biden administration’s decision Friday to end a deep cut in the hospitals’ Medicare Part B drug reimbursement in place since 2018. They urged the government to swiftly make 340B hospitals whole for their
…
×
*Sign up for news summaries and alerts from 340B Report
